Global Market Report

US PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market Report 2021-2031

Where the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.

SKU: PHA0956 Category: Tag: Code: PHA0956Pages: 212
Clear
← Back to category Therapeutic Drugs

Description

PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market-our new study reveals current trends, technological advancements, and predicted revenues

Where the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 210+ page report provides 150+ tables, 150+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

, In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors

, You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players

, Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.

Report Scope

US PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment market 2021-2031 is segmented on the basis of Treatment and End Users

• Revenue and growth forecasts from 2021 to 2031 for the US PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market by Treatment:

, Platelet Rich Plasma (PRP) Injections

, Stem Cell Therapy

• Revenue and growth forecasts from 2021 to 2031 for the US PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market by End User:

, Hospitals

, Dermatology Clinics

, Others

• Our study discusses the selected leading companies that are the major players in the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment industry:

, Orange County Hair Restoration Centre
,Hair Sciences Centre of Colorado
,Anderson Centre for Hair
,Evolution Hair Loss Institute
,Savola Aesthetic Dermatology Centre, PLC
,NovaGenix
,Virginia Surgical Centre
,Hair Transplant Institute of Miami
,Colorado Surgical Centre & Hair Institute
,Tampa Bay Hair Restoration

How the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market report helps you

In summary, our 190+ page report provides you with the following knowledge:
, Revenue forecasts to 2031 for each of the above mentioned segments each forecasted at a country level, growth of all segments on country level helps to understand most lucrative segment.

, Prospects for established firms and those seeking to enter the market, including company profiles for over 10 of the major companies involved in the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
COVID 19 Impact & Recovery Analysis on the Market
Currently, COVID-19 (Coronavirus) is prevalent across the globe. Many companies are underway to discover a vaccine, or therapeutics which can prevent or cure the COVID-19 virus. According to the World Health Organization, as of 13th September 2020, there were over 28,637,952 confirmed cases of COVID-19, with more than 917,417 deaths, globally.

The COVID-19 disease is continuously disrupting the growth of various markets. However, the immediate effect of the pandemic is different. Some industries will register a drop in demand, various other markets will remain unchanged and display a promising growth opportunities. The healthcare centers, such as hospitals and diagnostic labs, have been investing heavily in maintaining the supply of essential equipment and drugs. Due to lockdown across the globe, people were unable to reach healthcare facilities and non-urgent procedures were advised to put hold which impacted the healthcare industry a lot.

Due to COVID 19 pandemic patients were reluctant in visiting hospitals or clinics for their treatments and preferred virtual doctor visits. Lockdown across the globe due to the pandemic led to the delay of procedures which were not urgent. These factors negatively impacted the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment market for limited period of time. However, slowly the situation is getting back to normal everywhere and the market discussed is expected to increase in future.
Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment market and leading companies. You will find data, trends and predictions.

The PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market 2021-2031 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment industry.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today US PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market Report 2021-2031: Forecasts, by End User (Dermatology Clinics, Hospitals). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed , order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. End-User
1.6. Frequently Asked Questions (FAQ)
1.7. Associated VISIONGAIN Reports
1.8. About VISIONGAIN
2. Introduction to theU.S. PRP & Stem Cell Alopecia Treatment Market
2.1. U.S. PRP & Stem Cell Alopecia TreatmentMarket Definition
2.2. Treatment Outlook Submarkets Definitions
2.3. End-User Submarkets Definitions
2.4. Product Submarkets Definitions
3. U.S. PRP & Stem Cell Alopecia Treatment Market Overview
3.1. U.S. PRP & Stem Cell Alopecia Treatment Market Size and Forecast by Region
3.2. U.S. PRP & Stem Cell Alopecia Treatmentl Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Original treatments foremost to effective action and better patient results
3.3.2. Market Restraints/Challenges
3.3.2.1. Absence of repayment for PRP and stalk cell treatments in the U.S.
3.3.3. Opportunities
3.3.3.1. Opportunity 1
3.3.4. Trends
3.3.4.1. Trends 1
3.4. SWOT Analysis
3.4.1. Strengths
3.4.1.1. Strength 1
3.4.2. Weaknesses
3.4.2.1. Weakness 1
3.4.3. Opportunities
3.4.3.1. Opportunity 1
3.4.4. Threats
3.4.4.1. Threat 1
3.5. Porter's Five Forces Analysis
3.5.1. Competitive Rivalry
3.5.2. Supplier Power
3.5.3. Buyer Power
3.5.4. Threat of Substitution
3.5.5. Threat of New Entry
4. U.S. PRP & Stem Cell Alopecia Treatment Market Analysis and Forecast 2020-2030, by Treatment Outlook (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.2. Platelet Rich Plasma (PRP) Injections
4.3. Stem Cell Therapy
5. U.S. PRP & Stem Cell Alopecia Treatment Market Analysis and Forecast, 2020-2030 by End-User(Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.2. Hospitals
5.3. Dermatology Clinics
5.4. Other U.S. PRP & Stem Cell Alopecia Treatment
6. U.S. PRP & Stem Cell Alopecia Treatment Market Analysis and Forecast, 2020-2030 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North AmericaU.S. PRP & Stem Cell Alopecia Treatment Size and Forecast by Treatment Outlook
6.3. North AmericaU.S. PRP & Stem Cell Alopecia Treatment Market Size and Forecast byEnd-User
6.4. U.SU.S. PRP & Stem Cell Alopecia Treatment. Market
7. Companies in thePRP & Stem Cell Alopecia Treatment Market
7.1. Orange County Hair Restoration Centre
7.1.1. Company Snapshot
7.1.2. Company Overview
7.1.3. Financial Performance (2015-2019)
7.1.3.1. Net Revenue
7.1.3.2. Gross Profit
7.1.3.3. Geographical Revenue, 2019
7.1.4. Product Offerings
7.1.5. Recent Initiatives (2017-2019)
7.2. Hair Sciences Centre of Colorado.
7.2.1. Company Snapshot
7.2.2. Company Overview
7.2.3. Financial Performance (2015-2019)
7.2.3.1. Net Revenue
7.2.3.2. Gross Profit
7.2.3.3. Geographical Revenue, 2019
7.2.4. Product Offerings
7.2.5. Recent Initiatives (2017-2019)
7.3. Anderson Centre for Hair
7.3.1. Company Snapshot
7.3.2. Company Overview
7.3.3. Financial Performance (2015-2019)
7.3.3.1. Net Revenue
7.3.3.2. Gross Profit
7.3.3.3. Geographical Revenue, 2019
7.3.4. Product Offerings
7.3.5. Recent Initiatives (2017-2019)
7.4. Evolution Hair Loss Institute
7.4.1. Company Snapshot
7.4.2. Company Overview
7.4.3. Financial Performance (2015-2019)
7.4.3.1. Net Revenue
7.4.3.2. Gross Profit
7.4.3.3. Geographical Revenue, 2019
7.4.4. Product Offerings
7.4.5. Recent Initiatives (2017-2019)
7.5. Savola Aesthetic Dermatology Centre, Plc
7.5.1. Company Snapshot
7.5.2. Company Overview
7.5.3. Financial Performance (2015-2019)
7.5.3.1. Net Revenue
7.5.3.2. Gross Profit
7.5.3.3. Geographical Revenue, 2019
7.5.4. Product Offerings
7.5.5. Recent Initiatives (2017-2019)
7.6. NovaGenix.
7.6.1. Company Snapshot
7.6.2. Company Overview
7.6.3. Financial Performance (2015-2019)
7.6.3.1. Net Revenue
7.6.3.2. Gross Profit
7.6.3.3. Geographical Revenue, 2019
7.6.4. Product Offerings
7.6.5. Recent Initiatives (2017-2019)
7.7. Virginia Surgical Centre.
7.7.1. Company Snapshot
7.7.2. Company Overview
7.7.3. Financial Performance (2015-2019)
7.7.3.1. Net Revenue
7.7.3.2. Gross Profit
7.7.3.3. Geographical Revenue, 2019
7.7.4. Product Offerings
7.7.5. Recent Initiatives (2017-2019)
7.8. Hair Transplant Institute of Miami.
7.8.1. Company Snapshot
7.8.2. Company Overview
7.8.3. Financial Performance (2015-2019)
7.8.3.1. Net Revenue
7.8.3.2. Gross Profit
7.8.3.3. Geographical Revenue, 2019
7.8.4. Product Offerings
7.8.5. Recent Initiatives (2017-2019)
7.9. Colorado Surgical Centre & Hair Institute.
7.9.1. Company Snapshot
7.9.2. Company Overview
7.9.3. Financial Performance (2015-2019)
7.9.3.1. Net Revenue
7.9.3.2. Gross Profit
7.9.3.3. Geographical Revenue, 2019
7.9.4. Product Offerings
7.9.5. Recent Initiatives (2017-2019)
7.10. Tampa Bay Hair Restoration
7.10.1. Company Snapshot
7.10.2. Company Overview
7.10.3. Financial Performance (2015-2019)
7.10.3.1. Net Revenue
7.10.3.2. Gross Profit
7.10.3.3. Geographical Revenue, 2019
7.10.4. Product Offerings
7.10.5. Recent Initiatives (2017-2019)
7.11. Other Notable Players
8. Conclusion
9. Glossary
Associated VISIONGAIN Reports
VISIONGAIN Report Sales Order Form
Appendix A
About VISIONGAIN
Appendix B
VISIONGAIN report evaluation form


LIST OF TABLES
Table No 1: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 2: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 3: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 4: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 5: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 6: U.S. PRP & Stem Cell Alopecia Treatment Market Drivers & Restraints 2020
Table No 7: U.S. PRP & Stem Cell Alopecia Treatment Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (Before COVID)
Table No 8: U.S. PRP & Stem Cell Alopecia Treatment Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 9: U.S. PRP & Stem Cell Alopecia Treatment Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 10: U.S. PRP & Stem Cell Alopecia Treatment Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 11: U.S. PRP & Stem Cell Alopecia Treatment Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 12: Platelet Rich Plasma (PRP) Injections Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Table No 13: Platelet Rich Plasma (PRP) Injections Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 14: Platelet Rich Plasma (PRP) Injections Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 15: Platelet Rich Plasma (PRP) Injections Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 16: Platelet Rich Plasma (PRP) Injections Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 17: Stem Cell Therapy Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Table No 18: Stem Cell Therapy Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 19: Stem Cell Therapy Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 20: Stem Cell Therapy Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 21: Stem Cell Therapy Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 22: U.S. PRP & Stem Cell Alopecia Treatment Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (Before COVID)
Table No 23: U.S. PRP & Stem Cell Alopecia Treatment Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 24: U.S. PRP & Stem Cell Alopecia Treatment Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 25: U.S. PRP & Stem Cell Alopecia Treatment Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 26: U.S. PRP & Stem Cell Alopecia Treatment Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 27: Hospitals Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Table No 28: Hospitals Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 29: Hospitals Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 30: Hospitals Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 31: Hospitals Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 32: Dermatology Clinics Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Table No 33: Dermatology Clinics Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 34: Dermatology Clinics Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 35: Dermatology Clinics Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 36: Dermatology Clinics Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 37: Other Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Table No 38: Other Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 39: Other Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 40: Other Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 41: Other Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 42: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (Before COVID)
Table No 43: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 44: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 45: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 46: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 47: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (Before COVID)
Table No 48: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 49: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 50: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 51: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 52: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (Before COVID)
Table No 53: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 54: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 55: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 56: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-User 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 57: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (Before COVID)
Table No 58: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 59: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 60: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 61: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 62: Leading 10 U.S. PRP & Stem Cell Alopecia Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table No 63: Orange County Hair Restoration Centre. Profile (CEO, HQ, Founded, Website)
Table No 64: Orange County Hair Restoration Centre. (Total Company Sales 2016-2019 (US $Mn, AGR %)
Table No 65: Orange County Hair Restoration Centre. (Net Income 2016-2019 (US $Mn, AGR %)
Table No 66: Hair Sciences Centre of Colorado Profile (CEO, HQ, Founded, Website)
Table No 67: Hair Sciences Centre of Colorado (Total Company Sales 2016-2019 (US $Mn, AGR %)
Table No 68: Hair Sciences Centre of Colorado (Net Income 2016-2019 (US $Mn, AGR %)
Table No 69: Anderson Centre for Hair. Profile (CEO, HQ, Founded, Website)
Table No 70: Anderson Centre for Hair. (Total Company Sales 2016-2019 (US $Mn, AGR %)
Table No 71: Anderson Centre for Hair. (Net Income 2016-2019 (US $Mn, AGR %)
Table No 72: Evolution Hair Loss Institute Profile (CEO, HQ, Founded, Website)
Table No 73: Evolution Hair Loss Institute (Total Company Sales 2016-2019 (US $Mn, AGR %)
Table No 74: Evolution Hair Loss Institute (Net Income 2016-2019 (US $Mn, AGR %))
Table No 75: Savola Aesthetic Dermatology Centre, Plc Profile (CEO, HQ, Founded, Website)
Table No 76: Savola Aesthetic Dermatology Centre, Plc Profile (Total Company Sales 2016-2019 (US $Mn, AGR %)
Table No 77: Savola Aesthetic Dermatology Centre, Plc Profile (Net Income 2016-2019 (US $Mn, AGR %))
Table No 78: NovaGenix Profile (CEO, HQ, Founded, Website)
Table No 79: NovaGenix (Total Company Sales 2016-2019 (US $Mn, AGR %))
Table No 80: NovaGenix (Net Income 2016-2019 (US $Mn, AGR %))
Table No 81: Virginia Surgical Centre. Profile (CEO, HQ, Founded, Website)
Table No 82: Virginia Surgical Centre. (Total Company Sales 2016-2019 (US $Mn, AGR %))
Table No 83: Virginia Surgical Centre. (Net Income 2016-2019 (US $Mn, AGR %))
Table No 84: Hair Transplant Institute of Miami. Profile (CEO, HQ, Founded, Website)
Table No 85: Hair Transplant Institute of Miami. (Total Company Sales 2016-2019 (US $Mn, AGR %))
Table No 86: Hair Transplant Institute of Miami. (Net Income 2016-2019 (US $Mn, AGR %))
Table No 87: Colorado Surgical Centre & Hair Institute. (CEO, HQ, Founded, Website)
Table No 88: Colorado Surgical Centre & Hair Institute. (Total Company Sales 2016-2019 (US $Mn, AGR %))
Table No 89: Colorado Surgical Centre & Hair Institute. (Net Income 2016-2019 (US $Mn, AGR %))
Table No 90: Tampa Bay Hair Restoration Profile (CEO, HQ, Founded, Website)
Table No 91: Tampa Bay Hair Restoration (Total Company Sales 2016-2019 (US $Mn, AGR %))
Table No 92: Tampa Bay Hair Restoration (Net Income 2016-2019 (US $Mn, AGR %))
Table No 93: Other Companies U.S. PRP & Stem Cell Alopecia Treatment Market 2020 (Company, Location)


LIST OF FIGURES
Figure No 1: U.S. PRP & Stem Cell Alopecia Treatment Market Treatment Outlook Overview
Figure No 2: U.S. PRP & Stem Cell Alopecia Treatment Market End-Userr Overview
Figure No 3: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (Before COVID)
Figure No 4: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario V)
Figure No 5: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario U)
Figure No 6: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario W)
Figure No 7: U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario L)
Figure No 8: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by Treatment Outlook 2020-2030 (US$M, Global AGR %) (Before COVID)
Figure No 9: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by Treatment Outlook 2020-2030 (US$M, Global AGR %) (COVID - Scenario V)
Figure No 10: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by Treatment Outlook 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 11: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by Treatment Outlook 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 12: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by Treatment Outlook 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 13: Platelet Rich Plasma (PRP) Injections 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Figure No 14: Platelet Rich Plasma (PRP) Injections 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 15: Platelet Rich Plasma (PRP) Injections 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 16: Platelet Rich Plasma (PRP) Injections 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 17: Platelet Rich Plasma (PRP) Injections 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 18: Stem Cell Therapy Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Figure No 19: Stem Cell Therapy Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 20: Stem Cell Therapy Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 21: Stem Cell Therapy Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 22: Stem Cell Therapy Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 23: Stem Cell Products Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Figure No 24: Stem Cell Products Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 25: Stem Cell Products Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 26: Stem Cell Products Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 27: Stem Cell Products Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 28: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by End-User 2020-2030 (US$M, Global AGR %) (Before COVID)
Figure No 29: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by End-User 2020-2030 (US$M, Global AGR %) (COVID - Scenario V)
Figure No 30: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by End-User 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 31: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by End-User 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 32: U.S. PRP & Stem Cell Alopecia Treatment Submarket Forecast by End-User 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 33: Hospitals Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Figure No 34: Hospitals Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 35: Hospitals Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 36: HospitalsSubmarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 37: Hospitals Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 38: Dermatology Clinics Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Figure No 39: Dermatology Clinics Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 40: Dermatology Clinics Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 41: Dermatology Clinics Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 42: Dermatology Clinics Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 43: Other Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (Before COVID)
Figure No 44: Other Submarket Forecast 2020-2030 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 45: Other Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 46: Other Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 47: Other Submarket Forecast 2020-2030 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 48: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (Sales US$M, Global AGR %)
Figure No 49: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure No 50: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure No 51: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure No 52: Regional U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure No 53: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %) (Before COVID)
Figure No 54: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %) (COVID - Scenario V)
Figure No 55: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %) (COVID - Scenario U)
Figure No 56: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %) (COVID - Scenario W)
Figure No 57: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by Treatment Outlook 2020-2030 (US$M, AGR %) (COVID - Scenario L)
Figure No 58: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-Userr 2020-2030 (US$M, AGR %)
Figure No 59: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-Userr 2020-2030 (US$M, AGR %) (COVID - Scenario V)
Figure No 60: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-Userr 2020-2030 (US$M, AGR %) (COVID - Scenario U)
Figure No 61: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-Userr 2020-2030 (US$M, AGR %) (COVID - Scenario W)
Figure No 62: North America U.S. PRP & Stem Cell Alopecia Treatment Market Forecast by End-Userr 2020-2030 (US$M, AGR %) (COVID - Scenario L)
Figure No 63: US U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (Before COVID)
Figure No 64: US U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario V)
Figure No 65: US U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario U)
Figure No 66: US U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario W)
Figure No 67: US U.S. PRP & Stem Cell Alopecia Treatment Market Forecast 2020-2030 (US$M, AGR %) (COVID - Scenario L)
Figure No 68: Orange County Hair Restoration Centre. (Total Company Sales 2016-2019 (US $Mn, AGR %)
Figure No 69: Orange County Hair Restoration Centre. (Net Income 2016-2019 (US $Mn, AGR %)
Figure No 70: Hair Sciences Centre of Colorado (Total Company Sales 2016-2019 (US $Mn, AGR %)
Figure No 71: Hair Sciences Centre of Colorado (Net Income 2016-2019 (US $Mn, AGR %)
Figure No 72: Anderson Centre for Hair (Total Company Sales 2016-2019 (US $Mn, AGR %)
Figure No 73: Anderson Centre for Hair (Net Income 2016-2019 (US $Mn, AGR %)
Figure No 74: Evolution Hair Loss Institute (Total Company Sales 2016-2019 (US $Mn, AGR %)
Figure No 75: Evolution Hair Loss Institute (Net Income 2016-2019 (US $Mn, AGR %))
Figure No 76: Savola Aesthetic Dermatology Centre, Plc (Total Company Sales 2016-2019 (US $Mn, AGR %)
Figure No 77: Savola Aesthetic Dermatology Centre, Plc (Net Income 2016-2019 (US $Mn, AGR %))
Figure No 78: NovaGenix (Total Company Sales 2016-2019 (US $Mn, AGR %))
Figure No 79: NovaGenix (Net Income 2016-2019 (US $Mn, AGR %))
Figure No 80: Virginia Surgical Centre. (Total Company Sales 2016-2019 (US $Mn, AGR %))
Figure No 81: Virginia Surgical Centre. (Net Income 2016-2019 (US $Mn, AGR %))
Figure No 82: Hair Transplant Institute of Miami. (Total Company Sales 2016-2019 (US $Mn, AGR %))
Figure No 83: Hair Transplant Institute of Miami. (Net Income 2016-2019 (US $Mn, AGR %))
Figure No 84: Colorado Surgical Centre & Hair Institute. (Total Company Sales 2016-2019 (US $Mn, AGR %))
Figure No 85: Colorado Surgical Centre & Hair Institute. (Net Income 2016-2019 (US $Mn, AGR %))
Figure No 86: Tampa Bay Hair Restoration (Total Company Sales 2016-2019 (US $Mn, AGR %))
Figure No 87: Tampa Bay Hair Restoration (Net Income 2016-2019 (US $Mn, AGR %)) n, AGR %))

Companies Profiled in the Report


1. Orange County Hair Restoration Centre
2. Hair Sciences Centre of Colorado
3. Anderson Centre for Hair
4. Evolution Hair Loss Institute
5. Savola Aesthetic Dermatology Centre, PLC
6. NovaGenix
7. Virginia Surgical Centre
8. Hair Transplant Institute of Miami
List of Companies Mentioned in the Report:
1. Orange County Hair Restoration Centre
2. Hair Sciences Centre of Colorado
3. Anderson Centre for Hair
4. Evolution Hair Loss Institute
5. Savola Aesthetic Dermatology Centre, PLC
6. NovaGenix
7. Virginia Surgical Centre
8. Hair Transplant Institute of Miami
9. Colorado Surgical Centre & Hair Institute
10. Tampa Bay Hair Restoration
11. Kerastem
12. Eclipse
13. Regen Lab SA
14. Stemcell Technologies, Inc.
15. RepliCel Life Sciences
16. Histogen, Inc.
17. Glofinn Oy
18. Arthrex Inc.
19. DePuy Synthes
20. Terumo BCT Inc.
21. Zimmer Biomet
List of Organizations Mentioned in the Report:
Food and Drugs Administration
American Cancer Society
World Health Organization
American Hospital Association (AHA)
National Cancer Institute
NIH
CDC
Mayo Clinic